Metastatic Malignant Neoplasm in the Bone Clinical Trials
34 clinical trials for Metastatic Malignant Neoplasm in the Bone across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer — RECRUITING
- Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer — RECRUITING
- Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple Myeloma — RECRUITING · NA
- Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial — RECRUITING · NA
- Biology-Guided Radiation Therapy for the Treatment of Patients With Bone Metastases — RECRUITING · PHASE1
- Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study — ACTIVE_NOT_RECRUITING · PHASE3
- Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, RadiCaL Study — ACTIVE_NOT_RECRUITING · PHASE2
- Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones — ACTIVE_NOT_RECRUITING · PHASE2
- Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma — ACTIVE_NOT_RECRUITING · PHASE3
- Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer — COMPLETED · PHASE2
- Intraoperative Neuromonitoring of Sacral Reflexes to Predict Post Operative Function in Patients Undergoing Sacrectomy for Pelvic Bone Malignancy or Patients Undergoing Spinal Procedures Without Sacral Root Involvement — NOT_YET_RECRUITING · NA
- Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival — COMPLETED · PHASE2
- Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial — ACTIVE_NOT_RECRUITING · PHASE3
- Radiation Medication (Radium-223 Dichloride) Versus Radium-223 Dichloride Plus Radiation Enhancing Medication (M3814) Versus Radium-223 Dichloride Plus M3814 Plus Avelumab (a Type of Immunotherapy) for Advanced Prostate Cancer Not Responsive to Hormonal Therapy — SUSPENDED · PHASE1
- Testing the Safety of the Anti-cancer Drug, Sn-117m-DTPA, for Advanced Cancers That Have Spread to Bones — NOT_YET_RECRUITING · PHASE1
- Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer — TERMINATED · PHASE2
- Efficacy of Ra-223 in PSMA PET Optimally Selected Patients — ACTIVE_NOT_RECRUITING · PHASE2
- Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis — COMPLETED · NA
- Treatment of Cancer-Related Bone Pain by Using Bone-Targeted Radiation-Based Therapy (Sn-117m-DTPA) in Patients With Prostate Cancer That Has Spread to Bones — TERMINATED · PHASE2
- Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis — COMPLETED · PHASE2
- Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer — COMPLETED · PHASE2
- Genetic and Molecular Mechanisms in Assessing Response in Patients With Prostate Cancer Receiving Enzalutamide Therapy — COMPLETED · PHASE2
- 18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery — COMPLETED · NA
- Pembrolizumab and Ruxolitinib Phosphate in Treating Patients With Metastatic Stage IV Triple Negative Breast Cancer — COMPLETED · PHASE1
- Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers — COMPLETED · PHASE1
- Antiandrogen Therapy, Abiraterone Acetate, and Prednisone With or Without Neutron Radiation Therapy in Treating Patients With Prostate Cancer — TERMINATED · PHASE2
- Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer — COMPLETED · PHASE1
- 68Ga-PSMA-11 PET/CT for the Diagnosis of Bone Metastases in Patients With Prostate Cancer and Biochemical Progression During Androgen Deprivation Therapy — TERMINATED · PHASE2
- Telemonitoring After Surgery to Preserve Limb Function in Optimizing Mobility in Cancer Survivors With Skeletal Metastases — TERMINATED · NA
- BAY1895344 and Copanlisib for the Treatment of Molecularly Selected Patients With Advanced Solid Tumors — WITHDRAWN · PHASE1
- Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer — TERMINATED · PHASE1
- Radiation Therapy in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Receiving Sipuleucel-T — COMPLETED · NA
- NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate Cancer — TERMINATED · PHASE1
- Fluorine F 18 Sodium Fluoride Positron Emission Tomography in Evaluating Response to Dasatinib in Patients With Prostate Cancer and Bone Metastases — COMPLETED · PHASE2
Refine this search